130 related articles for article (PubMed ID: 24623229)
21. Mutagen sensitivity in upper aerodigestive tract cancer: a case-control analysis.
Spitz MR; Fueger JJ; Halabi S; Schantz SP; Sample D; Hsu TC
Cancer Epidemiol Biomarkers Prev; 1993; 2(4):329-33. PubMed ID: 7688625
[TBL] [Abstract][Full Text] [Related]
22. Inherited susceptibility to bleomycin-induced chromatid breaks in cultured peripheral blood lymphocytes.
Cloos J; Nieuwenhuis EJ; Boomsma DI; Kuik DJ; van der Sterre ML; Arwert F; Snow GB; Braakhuis BJ
J Natl Cancer Inst; 1999 Jul; 91(13):1125-30. PubMed ID: 10393720
[TBL] [Abstract][Full Text] [Related]
23. Bleomycin-induced mutagen sensitivity, passive smoking, and risk of breast cancer in Chinese women: a case-control study.
Hu M; Han D; Sun S; Yan Y; Zhang J; Zhou Y
Cancer Causes Control; 2013 Apr; 24(4):629-36. PubMed ID: 23371556
[TBL] [Abstract][Full Text] [Related]
24. Mutagen sensitivity as a marker of cancer susceptibility.
Spitz MR; Wu X; Jiang H; Hsu TC
J Cell Biochem Suppl; 1996; 25():80-4. PubMed ID: 9027602
[TBL] [Abstract][Full Text] [Related]
25. Mutagen sensitivity as a susceptibility marker for endometriosis.
Lin J; Zhang X; Chen Y
Hum Reprod; 2003 Oct; 18(10):2052-7. PubMed ID: 14507820
[TBL] [Abstract][Full Text] [Related]
26. Is there a genetic basis for lung cancer susceptibility?
Amos CI; Xu W; Spitz MR
Recent Results Cancer Res; 1999; 151():3-12. PubMed ID: 10337715
[TBL] [Abstract][Full Text] [Related]
27. Genetic susceptibility to cancer.
Spitz MR; Bondy ML
Cancer; 1993 Aug; 72(3 Suppl):991-5. PubMed ID: 8334675
[TBL] [Abstract][Full Text] [Related]
28. Mutagen sensitivity to benzo(a)pyrene diol epoxide and the risk of squamous cell carcinoma of the head and neck.
Wang LE; Sturgis EM; Eicher SA; Spitz MR; Hong WK; Wei Q
Clin Cancer Res; 1998 Jul; 4(7):1773-8. PubMed ID: 9676854
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.
Minard CG; Spitz MR; Wu X; Hong WK; Etzel CJ
Cancer; 2006 Jun; 106(12):2636-44. PubMed ID: 16703596
[TBL] [Abstract][Full Text] [Related]
30. Sensitivity to DNA damage induced by benzo(a)pyrene diol epoxide and risk of lung cancer: a case-control analysis.
Li D; Firozi PF; Wang LE; Bosken CH; Spitz MR; Hong WK; Wei Q
Cancer Res; 2001 Feb; 61(4):1445-50. PubMed ID: 11245449
[TBL] [Abstract][Full Text] [Related]
31. In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysis.
Wang LE; Xiong P; Strom SS; Goldberg LH; Lee JE; Ross MI; Mansfield PF; Gershenwald JE; Prieto VG; Cormier JN; Duvic M; Clayman GL; Weber RS; Lippman SM; Amos CI; Spitz MR; Wei Q
J Natl Cancer Inst; 2005 Dec; 97(24):1822-31. PubMed ID: 16368944
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of three methods for the detection of DNA single-strand breaks in human lymphocytes: alkaline elution, nick translation, and single-cell gel electrophoresis.
Leroy T; Van Hummelen P; Anard D; Castelain P; Kirsch-Volders M; Lauwerys R; Lison D
J Toxicol Environ Health; 1996 Apr; 47(5):409-22. PubMed ID: 8614012
[TBL] [Abstract][Full Text] [Related]
33. Benzo[a]pyrene diol epoxide-induced 9p21 aberrations associated with genetic predisposition to bladder cancer.
Hazra A; Grossman HB; Zhu Y; Luo S; Spitz MR; Wu X
Genes Chromosomes Cancer; 2004 Dec; 41(4):330-8. PubMed ID: 15390186
[TBL] [Abstract][Full Text] [Related]
34. Mutagen sensitivity and genetic variants in nucleotide excision repair pathway: genotype-phenotype correlation.
Lin J; Swan GE; Shields PG; Benowitz NL; Gu J; Amos CI; de Andrade M; Spitz MR; Wu X
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2065-71. PubMed ID: 17932354
[TBL] [Abstract][Full Text] [Related]
35. Haplotypes of DNMT1 and DNMT3B are associated with mutagen sensitivity induced by benzo[a]pyrene diol epoxide among smokers.
Leng S; Stidley CA; Bernauer AM; Picchi MA; Sheng X; Frasco MA; Van Den Berg D; Gilliland FD; Crowell RE; Belinsky SA
Carcinogenesis; 2008 Jul; 29(7):1380-5. PubMed ID: 18499700
[TBL] [Abstract][Full Text] [Related]
36. Mutagen sensitivity and environmental exposures as contributing causes of chromosome 3p losses in head and neck cancers.
Schantz SP; Huang Q; Shah K; Murty VV; Hsu TC; Yu G; Andersen PE; Huvos AG; Chaganti RS
Carcinogenesis; 2000 Jun; 21(6):1239-46. PubMed ID: 10837016
[TBL] [Abstract][Full Text] [Related]
37. [Mutagen sensitivity in patients with multiple primary tumors (MPT) of the head and neck region--quantitative and qualitative assessment based on bleomycin assay].
Wierzbicka M; Jarmuz M; Gajecka M; Kujawski M; Szyfter W; Szyfter K
Otolaryngol Pol; 2004; 58(3):441-9. PubMed ID: 15311585
[TBL] [Abstract][Full Text] [Related]
38. In vitro induction of benzo(a)pyrene diol epoxide-DNA adducts in peripheral lymphocytes as a susceptibility marker for human lung cancer.
Li D; Wang M; Cheng L; Spitz MR; Hittelman WN; Wei Q
Cancer Res; 1996 Aug; 56(16):3638-41. PubMed ID: 8705998
[TBL] [Abstract][Full Text] [Related]
39. 4-nitroquinoline-1-oxide-induced mutagen sensitivity and risk of cutaneous melanoma: a case-control analysis.
Wang LE; Li C; Xiong P; Gershenwald JE; Prieto VG; Duvic M; Lee JE; Grimm EA; Hsu TC; Wei Q
Melanoma Res; 2016 Apr; 26(2):181-7. PubMed ID: 24977319
[TBL] [Abstract][Full Text] [Related]
40. Gamma-radiation sensitivity and risk of glioma.
Bondy ML; Wang LE; El-Zein R; de Andrade M; Selvan MS; Bruner JM; Levin VA; Alfred Yung WK; Adatto P; Wei Q
J Natl Cancer Inst; 2001 Oct; 93(20):1553-7. PubMed ID: 11604478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
